PIRTOBRUTINIB
Clinical trials for PIRTOBRUTINIB explained in plain language.
Never miss a new study
Get alerted when new PIRTOBRUTINIB trials appear
Sign up with your email to follow new studies for PIRTOBRUTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug combo outsmart an aggressive lymphoma?
Disease control Not yet recruitingThis phase 2 trial is testing whether adding the targeted drug pirtobrutinib to a standard chemotherapy regimen (Pola-R-CHP) can improve outcomes for people newly diagnosed with a specific, harder-to-treat subtype of diffuse large B-cell lymphoma (Non-GCB DLBCL). The study will e…
Matched conditions: PIRTOBRUTINIB
Phase: PHASE2 • Sponsor: Changzhou No.2 People's Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a targeted drug boost standard chemo for aggressive lymphoma?
Disease control Not yet recruitingThis trial is testing whether adding pirtobrutinib, a targeted drug, to the standard R-CHOP chemotherapy regimen can improve outcomes for people with a specific subtype of diffuse large B-cell lymphoma (non-GCB DLBCL). The study will enroll about 34 adults with newly diagnosed di…
Matched conditions: PIRTOBRUTINIB
Phase: PHASE2 • Sponsor: Changzhou No.2 People's Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC